152 related articles for article (PubMed ID: 33295887)
21. Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins.
Herr D; Fraser HM; Konrad R; Holzheu I; Kreienberg R; Wulff C
Fertil Steril; 2013 May; 99(6):1749-58. PubMed ID: 23465821
[TBL] [Abstract][Full Text] [Related]
22. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.
Jeon BH; Jang C; Han J; Kataru RP; Piao L; Jung K; Cha HJ; Schwendener RA; Jang KY; Kim KS; Alitalo K; Koh GY
Cancer Res; 2008 Feb; 68(4):1100-9. PubMed ID: 18281485
[TBL] [Abstract][Full Text] [Related]
23. Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation.
Takaishi K; Komohara Y; Tashiro H; Ohtake H; Nakagawa T; Katabuchi H; Takeya M
Cancer Sci; 2010 Oct; 101(10):2128-36. PubMed ID: 20860602
[TBL] [Abstract][Full Text] [Related]
24. VCAM1-α4β1 integrin interaction mediates interstitial tissue reconstruction in 3-D re-aggregate culture of dissociated prepubertal mouse testicular cells.
Abe K; Kon S; Kameyama H; Zhang J; Morohashi KI; Shimamura K; Abe SI
Sci Rep; 2021 Sep; 11(1):18332. PubMed ID: 34526555
[TBL] [Abstract][Full Text] [Related]
25. Losartan protects against myocardial ischemia and reperfusion injury
Li Y; Yao Y; Li J; Chen Q; Zhang L; Wang QK
FASEB J; 2019 Jul; 33(7):8555-8564. PubMed ID: 30991833
[TBL] [Abstract][Full Text] [Related]
26. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
Kryczek I; Lange A; Mottram P; Alvarez X; Cheng P; Hogan M; Moons L; Wei S; Zou L; Machelon V; Emilie D; Terrassa M; Lackner A; Curiel TJ; Carmeliet P; Zou W
Cancer Res; 2005 Jan; 65(2):465-72. PubMed ID: 15695388
[TBL] [Abstract][Full Text] [Related]
27. Anti-VLA4/VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway.
Papayannopoulou T; Priestley GV; Nakamoto B
Blood; 1998 Apr; 91(7):2231-9. PubMed ID: 9516120
[TBL] [Abstract][Full Text] [Related]
28. Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model.
Akutagawa N; Nishikawa A; Iwasaki M; Fujimoto T; Teramoto M; Kitajima Y; Endo T; Shibuya M; Kudo R
Jpn J Cancer Res; 2002 Jun; 93(6):644-51. PubMed ID: 12079512
[TBL] [Abstract][Full Text] [Related]
29. Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients.
Adhikary T; Wortmann A; Finkernagel F; Lieber S; Nist A; Stiewe T; Wagner U; Müller-Brüsselbach S; Reinartz S; Müller R
BMC Genomics; 2017 Mar; 18(1):243. PubMed ID: 28327095
[TBL] [Abstract][Full Text] [Related]
30. Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin α4β1 system.
Chang AC; Chen PC; Lin YF; Su CM; Liu JF; Lin TH; Chuang SM; Tang CH
Cancer Lett; 2018 Jul; 426():47-56. PubMed ID: 29627497
[TBL] [Abstract][Full Text] [Related]
31. Markedly elevated levels of vascular endothelial growth factor in malignant ascites.
Zebrowski BK; Liu W; Ramirez K; Akagi Y; Mills GB; Ellis LM
Ann Surg Oncol; 1999 Jun; 6(4):373-8. PubMed ID: 10379858
[TBL] [Abstract][Full Text] [Related]
32. Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma.
Hu L; Hofmann J; Jaffe RB
Clin Cancer Res; 2005 Nov; 11(22):8208-12. PubMed ID: 16299254
[TBL] [Abstract][Full Text] [Related]
33. Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation.
Lane D; Goncharenko-Khaider N; Rancourt C; Piché A
Oncogene; 2010 Jun; 29(24):3519-31. PubMed ID: 20400979
[TBL] [Abstract][Full Text] [Related]
34. Paracrine VEGF/VE-cadherin action on ovarian cancer permeability.
Hu L; Ferrara N; Jaffe RB
Exp Biol Med (Maywood); 2006 Nov; 231(10):1646-52. PubMed ID: 17060686
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells injected into carotid artery to target focal brain injury home to perivascular space.
Andrzejewska A; Dabrowska S; Nowak B; Walczak P; Lukomska B; Janowski M
Theranostics; 2020; 10(15):6615-6628. PubMed ID: 32550893
[No Abstract] [Full Text] [Related]
36. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
Wang X; Gao S; Song L; Liu M; Sun Z; Liu J
Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900
[TBL] [Abstract][Full Text] [Related]
37. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
Luo JC; Toyoda M; Shibuya M
Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
[TBL] [Abstract][Full Text] [Related]
38. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
[TBL] [Abstract][Full Text] [Related]
39. Plasma VCAM1 levels correlate with disease severity in Parkinson's disease.
Perner C; Perner F; Gaur N; Zimmermann S; Witte OW; Heidel FH; Grosskreutz J; Prell T
J Neuroinflammation; 2019 May; 16(1):94. PubMed ID: 31068198
[TBL] [Abstract][Full Text] [Related]
40. JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
Kakogiannos N; Ferrari L; Giampietro C; Scalise AA; Maderna C; Ravà M; Taddei A; Lampugnani MG; Pisati F; Malinverno M; Martini E; Costa I; Lupia M; Cavallaro U; Beznoussenko GV; Mironov AA; Fernandes B; Rudini N; Dejana E; Giannotta M
Circ Res; 2020 Sep; 127(8):1056-1073. PubMed ID: 32673519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
